FDG-PET in the assessment of metabolic response in patients with NSCLC treated with nivolumab: Preliminary results.

被引：0
|
作者：
Goldfarb, Lucas
Duchemann, Boris
Chouahnia, Kader
Gomez, Lea
Pop, Gabriel
Zelek, Laurent
Soussan, Michael
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.e20554
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e20554
引用
收藏
页数：5
相关论文
共 50 条
  • [1] FDG-PET in the assessment of metabolic response in patients with NSCLC treated with nivolumab: Preliminary results
    Goldfarb, L.
    Duchemann, B.
    Chouahnia, A.
    Pop, G.
    Gomez, L.
    Zelek, L.
    Soussan, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S673 - S673
  • [2] Assessment of Response of FDG-PET Using Total Lesion Glycolysis (TLG) in NSCLC Patients Treated with Nivolumab: Results of a Pilot Study
    Fichera, Giulia
    Aiello, Marco
    Noto, Laura
    Restuccia, Nunzio
    Ippolito, Massimo
    Parra, Hector Soto
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S551 - S551
  • [3] Metabolic activity by 18F–FDG-PET/CT is predictive of early response after nivolumab in previously treated NSCLC
    Kyoichi Kaira
    Tetsuya Higuchi
    Ichiro Naruse
    Yukiko Arisaka
    Azusa Tokue
    Bolag Altan
    Satoshi Suda
    Akira Mogi
    Kimihiro Shimizu
    Noriaki Sunaga
    Takeshi Hisada
    Shigehisa Kitano
    Hideru Obinata
    Takehiko Yokobori
    Keita Mori
    Masahiko Nishiyama
    Yoshihito Tsushima
    Takayuki Asao
    European Journal of Nuclear Medicine and Molecular Imaging, 2018, 45 : 56 - 66
  • [4] [18F]-FDG-PET/CT Early Response to Nivolumab in NSCLC
    Bellevre, Dimitri
    Petyt, Gegory
    Collet, Guillaume
    Hossein-Foucher, Claude
    Baldacci, Simon
    Baranzelli, Anne
    Semah, Franck
    Cortot, Alexis
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S402 - S402
  • [5] [18F]-FDG-PET/CT early response to nivolumab in NSCLC
    Bellevre, Dimitri
    Petyt, Gregory
    Collet, Guillaume
    Hossein-Foucher, Claude
    Semah, Franck
    Cortot, Alexis
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57
  • [6] FDG-PET and isolated limb perfusion therapy in patients with locally advanced melanoma: Preliminary results.
    Mercier, G
    Alavi, A
    Fraker, D
    JOURNAL OF NUCLEAR MEDICINE, 1998, 39 (05) : 95P - 95P
  • [7] EARLY PREDICTIVE VALUE POST CHEMOTHERAPY OF METABOLIC RESPONSE ASSESSMENT USING FDG-PET IN NSCLC
    Meniawy, T.
    Davidson, A.
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (03) : S26 - S26
  • [8] Metabolic metrics in repeated FDG-PET scans show early treatment response for NSCLC patients
    Carvalho, S.
    Leijenaar, R.
    Velazquez, E. Rios
    Van Elmpt, W.
    Oberije, C.
    Troost, E.
    Dekker, A.
    Aerts, H.
    Lambin, P.
    RADIOTHERAPY AND ONCOLOGY, 2014, 111 : S45 - S45
  • [9] Therapeutic response assessment using [18F]-FDG-PET/CT in NSCLC patients treated with immune checkpoint inhibitors
    Derijckere, I. Duran
    Gohimont, N.
    Karfis, I.
    Critchi, G.
    Berghmans, T.
    Flamen, P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S81 - S81
  • [10] FDG-PET metabolic tumor volume in advanced melanoma treated with ipilimumab and nivolumab (ipi/nivo).
    Iravani, Amir
    Wallace, Roslyn
    Lo, Serigne
    Galligan, Anna
    Weppler, Alison
    Au-Yeung, George
    Kee, Damien
    Lau, Peter Kar Han
    Brady, Benjamin M.
    Lee, Belinda
    McArthur, Grant A.
    Sandhu, Shahneen Kaur
    Hicks, Rodney J.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
12345